Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax® compared with Turbuhaler® in patients with moderate-to-severe chronic obstructive pulmonary disease in S (Q37645807)
Jump to navigation
Jump to search
scientific article published on 10 February 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax® compared with Turbuhaler® in patients with moderate-to-severe chronic obstructive pulmonary disease in S |
scientific article published on 10 February 2017 |
Statements
1 reference
Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax® compared with Turbuhaler® in patients with moderate-to-severe chronic obstructive pulmonary disease in S (English)
1 reference
Josep Darbà
1 reference
Gabriela Ramírez
1 reference
Juan L García-Rivero
1 reference
Sagrario Mayoralas
1 reference
José Francisco Pascual
1 reference
Diego Vargas
1 reference
Adi Bijedic
1 reference
10 February 2017
1 reference
1 reference
127-137
1 reference
1 February 2017
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference